ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
68,958.61
-0.45%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Miragen Therapeutics Inc (MGEN)

  7. Miragen Therapeutics Inc (MGEN) News

Miragen Therapeutics (MGEN)

Miragen Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MGEN
DateTimeSourceHeadlineSymbolCompany
20/06/202322:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MGENMiragen Therapeutics Inc
17/06/202300:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MGENMiragen Therapeutics Inc
09/05/202321:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MGENMiragen Therapeutics Inc
28/04/202313:29Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:MGENMiragen Therapeutics Inc
28/04/202313:27Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:MGENMiragen Therapeutics Inc
28/04/202313:25Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MGENMiragen Therapeutics Inc
13/04/202300:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MGENMiragen Therapeutics Inc
12/04/202313:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MGENMiragen Therapeutics Inc
13/03/202320:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MGENMiragen Therapeutics Inc
10/03/202322:08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:MGENMiragen Therapeutics Inc
10/03/202321:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MGENMiragen Therapeutics Inc
10/03/202320:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MGENMiragen Therapeutics Inc
09/03/202312:25Edgar (US Regulatory)Annual Report (10-k)NASDAQ:MGENMiragen Therapeutics Inc
08/03/202312:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MGENMiragen Therapeutics Inc
14/02/202321:55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MGENMiragen Therapeutics Inc
14/02/202320:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MGENMiragen Therapeutics Inc
14/02/202319:24Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MGENMiragen Therapeutics Inc
14/02/202316:43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MGENMiragen Therapeutics Inc
14/02/202314:00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MGENMiragen Therapeutics Inc
14/02/202311:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MGENMiragen Therapeutics Inc
10/02/202321:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MGENMiragen Therapeutics Inc
10/02/202321:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MGENMiragen Therapeutics Inc
10/02/202321:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MGENMiragen Therapeutics Inc
10/02/202321:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MGENMiragen Therapeutics Inc
09/02/202317:02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MGENMiragen Therapeutics Inc
07/02/202323:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MGENMiragen Therapeutics Inc
07/02/202323:46Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MGENMiragen Therapeutics Inc
07/02/202323:35Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:MGENMiragen Therapeutics Inc
06/02/202312:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MGENMiragen Therapeutics Inc
03/02/202323:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MGENMiragen Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MGEN

Your Recent History

LSE
VAST
Vast Resources
LSE
LLOY
Lloyds Banking
LSE
NG.
National Grid
LSE
OPTI
Optibiotix Health
LSE
POS
Plexus
LSE
BARC
Barclays
LSE
CUSN
Cornish Metals
LSE
BOO
Boohoo
LSE
FDEV
Frontier Developments
LSE
IQE
Iqe
LSE
GOLD
LSE
GDR
Genedrive
LSE
TEK
Tekcapital
LSE
ITV
Itv
LSE
WG.
Wood Group (john)
LSE
OTB
On The Beach
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved